Actively Recruiting
Evaluating Upadacitinib Compared to Placebo for Severe Alopecia Areata in Children and Adolescents
Led by AbbVie · Updated on 2026-10-27
300
Participants Needed
14
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying severe alopecia areata AA, a condition where the immune system attacks hair follicles causing hair loss on the scalp and face, in pediatric patients aged 6 to under 18 years. The study evaluates the safety and effectiveness of upadacitinib, an investigational Janus-Kinase JAK inhibitor, compared to placebo. This phase 3, randomized, double-blind, placebo-controlled trial addresses the need for systemic treatments approved for young patients, as current options may not work or lose effectiveness over time. Participants are randomly assigned to one of three groups two different doses of upadacitinib or a matching placebo. The study lasts approximately 160 weeks and includes a 35-day screening period, a 24-week placebo-controlled treatment phase Period A, a 28-week blinded extension Period B, a 108-week long-term extension Period C, and a 30-day follow-up. Those initially on placebo who do not achieve sufficient hair regrowth may switch to upadacitinib during the extension periods. During the study, participants attend regular hospital or clinic visits for medical assessments, blood tests, questionnaires, and side effect monitoring. The main outcome measured is the percentage of participants achieving a Severity of Alopecia Tool SALT score indicating 20% or less scalp hair loss at Week 24. Researchers also track adverse events through Week 160 and assess other measures related to hair loss, quality of life, anxiety, and depression. Participants adherence and safety are closely monitored throughout the long study duration.
CONDITIONS
Brief Title
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
Research Team
A
ABBVIE CALL CENTER
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here